Articles Tagged With:
-
Trial Underway for Vaginal Ring Device Designed for HIV Prevention
Researchers are evaluating a vaginal ring designed to protect women against both HIV and herpes simplex virus type 2 in a Phase I study. The trial is being conducted by researchers from the National Institutes of Health-funded Microbicide Trials Network at three U.S. sites in Alabama, California, and Pennsylvania.
-
FDA Approves New Test for Mycoplasma genitalium
The Food and Drug Administration has approved the first test to help with the diagnosis of Mycoplasma genitalium, a sexually transmitted infection.
-
Researchers Investigate Microneedle Skin Patch Technology for Contraception Delivery
Researchers are studying microneedle skin patch technology for providing a long-acting contraceptive method that can be self-administered.
-
Providers Can Improve Teen HPV Vaccination Rates
According to a new study, only about 16% of U.S. adolescents have received the complete vaccination against human papillomavirus (HPV) by the time they turn 13 years of age, despite national recommendations for vaccination at ages 11-12.
-
Counseling on Contraceptive Use for Patients With Coexisting Medical Conditions
The American College of Obstetricians and Gynecologists has released a practice bulletin to help providers use scientific evidence to guide women with coexisting medical conditions in making the most effective choices.
-
Federal Agencies Address Public Health Emergency Responses
Updated guidance and protocols aim to help responders handle large-scale health disasters in a more timely fashion and with better tools.
-
It’s American Heart Month at Relias Media
Learn more about all the valuable cardiology resources available right now.
-
Study: Targeting Prescription Misuse Alone Not Enough to Turn the Tide in Opioid Fight
Investigators say multipronged approach key to moving beyond only modest improvements.
-
Revefenacin Oral Inhalation (Yupelri)
Revefenacin should be used to help patients with COPD.
-
Antipsychotics Do Not Shorten the Duration of ICU Delirium
In this randomized, placebo-controlled trial, neither haloperidol nor ziprasidone altered the duration of delirium when compared to placebo.